Nucleotide reverse transcriptase inhibitors formulated as oral tablets for antiretroviral therapy in HIV management. Pharmaceutical manufacturers supply to wholesalers and distributors, procured by hospitals, clinics, and HIV treatment programs for adult and pediatric patient regimens.